Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole in Preterm Infants With Gastroesophageal Reflux
NCT01778101Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2013
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lansoprazole in gastroesophageal reflux disease (GERD), sponsored by Seoul National University Hospital. Started Jan 2013; status: completed.
02
Drugs
lansoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01778101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01778101.